CAS Beijing Institute of Genomics and Purple Xin Pharmaceutical Co. will cooperate on 2nd generation DNA sequencer development

Based on IP of CAS, e. g. on a 2D CCD camera, Purple Xin Pharmaceuticals, a Ginseng-based company, will diversify into sequencer manufacturing through ist Jilin subsidiary Zhongke Zixin.

China Bio news release, October 30, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny